What Do I Need to Know About Alcoa Stock?
Alcoa (AA) is a global leader in aluminum production. Based…
Sell
6
ZVSA Quote, Financials, Valuation and Earnings
Last price:
$0.62
Seasonality move
:
-46.45%
Day range:
$0.59 - $0.67
52-week range:
$0.58 - $8.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.18x
Volume:
24.3K
Avg. volume:
304.3K
1-year change:
-91.66%
Market cap:
$1.5M
Revenue:
--
EPS (TTM):
-$113.75
Earnings Data
Next earnings date for ZVSA
--
Most recent earnings per share
-$0.57
Missed by $0.57
(Dec 31/2024)
Consensus Estimate
--
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZVSA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.40 | -- |
| 12/31/2024 | Q4 | -- | -- | -$0.57 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.43 | -$1.60 | -$0.83 |
| 06/30/2024 | Q2 | -- | -- | -$33.10 | -$3.75 | -$29.35 |
| 03/31/2024 | Q1 | -- | -- | -$45.30 | -$3.70 | -$41.60 |
| 12/31/2023 | Q4 | -- | -- | -$32.92 | -$21.40 | -$11.52 |
| 09/30/2023 | Q3 | -- | -- | -$30.18 | -$56.00 | $25.82 |
| 06/30/2023 | Q2 | -- | -- | -$1,694.12 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$1,358.80 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$177.37 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$515.54 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$35.00 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$54.17 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$28.45 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$27.16 | -- | -- |
ZyVersa Therapeutics Earnings Questions
-
How Much did ZyVersa Therapeutics Generate in Revenue Last Quarter?
ZyVersa Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did ZyVersa Therapeutics Beat Earnings Last Quarter?
ZyVersa Therapeutics announced earnings per share of -$0.57 which represents a miss of analyst forecast a -- per share.
-
Is ZyVersa Therapeutics Profitable?
ZyVersa Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ZyVersa Therapeutics EPS Next Year?
ZyVersa Therapeutics's earnings are forecast to decrease from -$8.48 per share to -$12.43 per share next year representing a decrease of -98.86%.
-
When is ZyVersa Therapeutics's Earnings Date?
Currently, ZyVersa Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on July 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is ROOT Stock the Next Big Thing?
Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…
Is Okta a Good Stock to Buy?
Okta (NASDAQ:OKTA) is used by some of the largest firms…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 7
Regencell Bioscience Holdings [RGC] is down 1.12% over the past day.
Sell
25
GDXU alert for Apr 7
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 0.4% over the past day.
Buy
76
SOXS alert for Apr 7
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 4.46% over the past day.
